title: [Application of technetium-99m labelled sandostatin Somatostatin receptor imaging in the detection of lung cancer].
abstract: OBJECTIVE
  To evaluate the clinical value of (99)Tc(m)-sandostatin receptors imaging ((99)Tc(m)-sandostatin) in detection of lung tumors in comparison with fludeoxyglucose F18 dual head coincidence imaging ((18)F-FDG DHC).
  
  
  METHODS
  Fifty-six consecutive patients (40 men, 16 women; mean age: 62 years, range 35 - 80 years) with pulmonary neoplasm were referred for evaluation. All underwent sandostatin scintigraphy using hybrid SPECT/CT. (18)F-FDG DHC imaging was also performed in 23 patients using the same camera. The tumor uptake of (99)Tc(m)-sandostatin and (18)F-FDG DHC were measured respectively and expressed as the ratio of T/Nr and T/Nm. Final clinical diagnosis was confirmed by histopathological study.
  
  
  RESULTS
  Out of 56 cases, 46 were confirmed to be malignant and 10 benign. The sensitivity, specificity and accuracy of (99)Tc(m)-sandostatin in diagnosis of lung cancer were 95.7%, 90.0%, 94.6%, respectively. The positive predictive value (PPR) was 97.8%, and the negative predictive value (NPR) was 81.8%. In the 23 patients underwent both methods, the sensitivity, specificity and accuracy of (18)F-FDG DHC were 100%, 60.0%, 82.6%, respectively; the PPR was 76.5%, and the NPR 100%. Out of 13 patients with malignant neoplasms, 6 patients had regional lymph node metastasis, and all of 10 abnormal lymph nodules showed high uptake of FDG, while (99)Tc(m)-sandostatin imaging only 2 regional metastasized lymph nodes in one patient. T/N(r) and T/N(m) were 3.15 +/- 1.30, and 10.61 +/- 4.35 respectively. There was no relationship between sandostatin uptake and glucose metabolism.
  
  
  CONCLUSIONS
  (99)Tc(m)-sandostatin scintigraphy is a promising noninvasive imaging technique for detection of the primary tumor of lung cancer but of limited value in the detection of lymph node metastasis.
authors.affiliation: Nuclear Medicine Department, First Affiliated Hospital, Nanjing Medical University, Nanjing 210006, China.
authors.forename: Feng
authors.initials: F
authors.lastname: Wang
authors.forename: Zi-zheng
authors.initials: ZZ
authors.lastname: Wang
authors.forename: Wei-xuan
authors.initials: WX
authors.lastname: Yao
authors.forename: Zheng-guo
authors.initials: ZG
authors.lastname: Chen
authors.forename: Hong
authors.initials: H
authors.lastname: Xie
authors.forename: Chong-ying
authors.initials: CY
authors.lastname: Xu
authors.forename: Qing-le
authors.initials: QL
authors.lastname: Meng
authors.forename: Yan
authors.initials: Y
authors.lastname: Cao
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002283:Carcinoma, Bronchogenic / Q000000981:diagnostic imaging; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D017481:Receptors, Somatostatin; D013667:Technetium; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D014057:Tomography, X-Ray Computed
chemical_list: D017481:Receptors, Somatostatin; D019788:Fluorodeoxyglucose F18; D013667:Technetium